Juvenile Hyaline Fibromatosis is a rare genetic disorder characterized by the abnormal growth of fibrous tissue in various parts of the body. It primarily affects children and is inherited in an autosomal recessive manner, meaning both parents must carry the mutated gene for their child to develop the condition.
The hallmark feature of Juvenile Hyaline Fibromatosis is the formation of tumor-like growths called fibromas, which can appear on the skin, joints, and other connective tissues. These fibromas are typically painless but can cause functional impairments depending on their size and location.
Other symptoms may include joint stiffness, limited mobility, and skeletal abnormalities. In severe cases, internal organs such as the lungs and heart may be affected, leading to potentially life-threatening complications.
Diagnosis of Juvenile Hyaline Fibromatosis is based on clinical evaluation, imaging studies, and genetic testing. Unfortunately, there is no cure for this condition, and treatment mainly focuses on managing symptoms and improving quality of life. Surgical removal of fibromas and physical therapy may be recommended to alleviate functional limitations.
Due to its rarity, support groups and research organizations play a crucial role in raising awareness, providing resources, and promoting scientific advancements for Juvenile Hyaline Fibromatosis.